SE8305163L - Dna-overforingsvektor med tillvexthormonkodoner, forfarande for dess framstellning samt en nemnda vektor innehallande mikroorganism jemte dess framstellning - Google Patents

Dna-overforingsvektor med tillvexthormonkodoner, forfarande for dess framstellning samt en nemnda vektor innehallande mikroorganism jemte dess framstellning

Info

Publication number
SE8305163L
SE8305163L SE8305163A SE8305163A SE8305163L SE 8305163 L SE8305163 L SE 8305163L SE 8305163 A SE8305163 A SE 8305163A SE 8305163 A SE8305163 A SE 8305163A SE 8305163 L SE8305163 L SE 8305163L
Authority
SE
Sweden
Prior art keywords
cdna
fragments
population
fragment
sub
Prior art date
Application number
SE8305163A
Other languages
English (en)
Other versions
SE8305163D0 (sv
Inventor
H M Goodman
P H Seeburg
J Shine
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of SE8305163L publication Critical patent/SE8305163L/sv
Publication of SE8305163D0 publication Critical patent/SE8305163D0/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57518Placental lactogen; Chorionic somatomammotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Claims (1)

Patentkrav Ffirfarande fir framstallning as en overforingsvektor, son har on fOr humant tillvaxformon kodande nukleotidsekvens, varvid man Lsolerar vavnad fran human hypofys, isolerar en mRNA-population or donna hypofysvavnad, syntetiserar en cDNA-population utgaende fran namnda mANA, ur derma sistnamnda population renar cDNA kodande fir humant tillvaxthormon och bringer denna renade cDNA att reagera med en DNA-overfOringsvektor, och varvid namnda renade oDNA utgar en mindre andel i namnda cDNA-population, itminstone en del av cDNA-molekylerna har minst tub restriktionsstallen, och namnda cDNA-population Or heterogen i fraga om langd och sekvens och framstalles utgiende frin namnda,i fraga on langd och sekvens heterogena mRNA-populationnedelst en med reverstranskriptas katalyserad reaktion,kannetecknat a v att naranda fir humant tillvaxthormon kodande cDNA renas medelst ett forfarande som innefattar foljande steq: al cDNA-populationen hydrolyseras enzymatiskt specifikt vid namda restriktionsstallen genom inkubation aven reaktionsblandning, innehallande cDNA-poionen och et. dessa restriktionsstallen specifikt restriktiononukleas, t.nkubation av namnda popu- t-
1. -d) ails ev. 5'-fosfat5ndgrupper pi cDNA-fragmenten hydrolyseras, ten. genom att fragmenten inkuberas med alkaliskt fosfatas vid pH 7,5 och 60°C under 10 minuter, el namnda cDNA-fragment hydrolyseras enzymatiskt specifikt vid namnda restriktionsst011e genom :lnkubation av en reaktionsblandning, som innehaller namnda fragment och ett fir detta restriktionsstalle specifikt restriktionsendonukleas, t.ex. inkubation av namnda fragment med PvuIT vid pH 7,6 och 37°C under 2 timmar, varvid delfragment bildas, son utgOres av delar av namnda fragment, 6. delfragmenten fraktioneras alltefter sin langd, t.ex. medelst gelelektrofores, 7. man uppsamlar de fraktoner, son innehiller de bade fir humant tillvaxthormon kodande delfragmenten av namnda cDNA, 8. delfragmenten sannunbindes Ater kovalent, vilket sker enzymetiskt i det att man inkuberar en reaktionsblandning, innehallande DNA-ligas, ATP och de hada delfragmenten,t. ex. inkuberar namnda DNA-ligas, delfragment och ATP vid pH 7,6 och °C under 2 timmar, varvid man erhaller ett fragment av cDNA som kodar fir humant tillvaxthormon, och I) de ligasbehandlade cDNA fraktioneras alltefter sin langd, tax. medels, gelelektrofores, och man uppsamlar den fraktion, son innehaller ett for humant tillvaxrmon kodande eDNA-fragment, sem darigenom erhalhuvudsak fr_ran kontaminerande cDNA-sekvensel
SE8305163A 1977-09-23 1983-09-23 Dna-overforingsvektor med tillvexthormonkodoner, forfarande for dess framstellning samt en nemnda vektor innehallande mikroorganism jemte dess framstellning SE8305163D0 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83621877A 1977-09-23 1977-09-23

Publications (2)

Publication Number Publication Date
SE8305163L true SE8305163L (sv) 1983-09-23
SE8305163D0 SE8305163D0 (sv) 1983-09-23

Family

ID=25271469

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7806087A SE7806087L (sv) 1977-09-23 1978-05-26 Forfarande for rening av nukleotidsekvenser lempliga som syntetiseringsmall i bakterier, mikroorganism innefattande dylik nukleotidsekvens samt rekombinant dna-overforingsvektor innefattande dylik nukleotid
SE8305162A SE8305162L (sv) 1977-09-23 1983-09-23 Dna-overforingsvektor med korionsomatomammotropinkodoner, forfarande for dess framstellning, samt en nemnda vektor innehallande mikroorganism jemte dess framstellning
SE8305163A SE8305163D0 (sv) 1977-09-23 1983-09-23 Dna-overforingsvektor med tillvexthormonkodoner, forfarande for dess framstellning samt en nemnda vektor innehallande mikroorganism jemte dess framstellning

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7806087A SE7806087L (sv) 1977-09-23 1978-05-26 Forfarande for rening av nukleotidsekvenser lempliga som syntetiseringsmall i bakterier, mikroorganism innefattande dylik nukleotidsekvens samt rekombinant dna-overforingsvektor innefattande dylik nukleotid
SE8305162A SE8305162L (sv) 1977-09-23 1983-09-23 Dna-overforingsvektor med korionsomatomammotropinkodoner, forfarande for dess framstellning, samt en nemnda vektor innehallande mikroorganism jemte dess framstellning

Country Status (25)

Country Link
JP (1) JPS5448775A (sv)
AT (2) AT369386B (sv)
AU (1) AU519528B2 (sv)
BE (1) BE868853A (sv)
CS (1) CS235069B2 (sv)
DD (2) DD145917A5 (sv)
DE (1) DE2825595A1 (sv)
DK (1) DK233378A (sv)
ES (1) ES470340A1 (sv)
FI (1) FI64187C (sv)
FR (1) FR2404013A1 (sv)
GB (1) GB1568047A (sv)
GR (1) GR73558B (sv)
IE (1) IE47332B1 (sv)
IL (1) IL54791A (sv)
IT (1) IT1098340B (sv)
LU (1) LU79938A1 (sv)
NL (1) NL7806358A (sv)
NZ (1) NZ187342A (sv)
PL (1) PL209748A1 (sv)
PT (1) PT68127A (sv)
RO (2) RO78407A (sv)
SE (3) SE7806087L (sv)
YU (1) YU214378A (sv)
ZA (1) ZA782933B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR7807290A (pt) * 1977-11-08 1979-06-12 Genentech Inc Plasmideo,processo para producao de um polipeptido especifico veiculo clonal,cultura bacteriana transformante,processo para produzir uma substancia imunogenica processo para preparar um gene estrutural,e polidesoxirribonucleotido de faixa dupla
US6270955B1 (en) 1978-12-22 2001-08-07 Biogen, Inc. Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
ZA802992B (en) * 1979-06-01 1981-10-28 Univ California Human pre-growth hormone
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
IL59690A (en) 1980-03-24 1983-11-30 Yeda Res & Dev Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
KR860001471B1 (ko) 1980-04-03 1986-09-26 비오겐 엔. 브이 인체의 섬유아세포 인터페론(IFN-β)폴리펩티드의 제조방법
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
CH659826A5 (fr) * 1981-06-02 1987-02-27 Wakunaga Yakuhin Kk Procede d'obtention d'un microorganisme transforme par un plasmide comprenant un gene de structure de la 27-desamidosecretine.
US5670371A (en) * 1983-07-15 1997-09-23 Bio-Technology General Corp. Bacterial expression of superoxide dismutase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ187300A (en) * 1977-05-27 1982-08-17 Univ California Dna transfer vector and micro-organism modified to contain a nucleotide sequence equivalent to the gene of a higher organism
AT373281B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur herstellung eines strukturgens

Also Published As

Publication number Publication date
IT1098340B (it) 1985-09-07
PT68127A (en) 1978-07-01
RO80006A (ro) 1982-10-11
NZ187342A (en) 1983-09-02
AT369386B (de) 1982-12-27
FI64187C (fi) 1983-10-10
GR73558B (sv) 1984-03-15
BE868853A (fr) 1978-11-03
LU79938A1 (sv) 1978-12-12
DK233378A (da) 1979-03-24
JPS5448775A (en) 1979-04-17
ES470340A1 (es) 1979-09-16
NL7806358A (nl) 1979-03-27
FR2404013B1 (sv) 1983-07-22
AT375673B (de) 1984-08-27
FR2404013A1 (fr) 1979-04-20
PL209748A1 (sv) 1979-12-03
SE8305162D0 (sv) 1983-09-23
FI64187B (fi) 1983-06-30
ATA456678A (de) 1982-05-15
SE8305163D0 (sv) 1983-09-23
ZA782933B (en) 1979-05-30
GB1568047A (en) 1980-05-21
IT7824641A0 (it) 1978-06-16
YU214378A (en) 1984-04-30
CS235069B2 (en) 1985-04-16
SE7806087L (sv) 1979-03-24
ATA248881A (de) 1984-01-15
AU3648978A (en) 1979-11-29
SE8305162L (sv) 1983-09-23
AU519528B2 (en) 1981-12-10
IE47332B1 (en) 1984-02-22
IE781054L (en) 1979-03-23
IL54791A (en) 1983-07-31
FI781676A (fi) 1979-03-24
DD145917A5 (de) 1981-01-14
RO78407A (ro) 1982-02-26
DD153393A5 (de) 1982-01-06
DE2825595A1 (de) 1979-04-12

Similar Documents

Publication Publication Date Title
SE8305163L (sv) Dna-overforingsvektor med tillvexthormonkodoner, forfarande for dess framstellning samt en nemnda vektor innehallande mikroorganism jemte dess framstellning
Siu et al. The structure, rearrangement and expression of D β gene segments of the murine T-cell antigen receptor
Bachali et al. Phylogenetic analysis of invertebrate lysozymes and the evolution of lysozyme function
Bui et al. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas
Juan et al. Mitochondrial DNA phylogeny and sequential colonization of Canary Islands by darkling beetles of the genus Pimelia (Tenebrionidae)
Ringuette et al. Molecular analysis of cDNA coding for ZP3, a sperm binding protein of the mouse zona pellucida
EP1174509A1 (en) Novel cytidine deaminase
Luo et al. Independent evolution of Toll and related genes in insects and mammals
TWI357906B (en) Neutralizing epitope-based growth enhancing vaccin
NO305604B1 (no) FremgangsmÕte for fremstilling av 3<alfa>-hydroksy-3<beta>-substituert-5<alfa>- pregnan-20-on-forbindelser
US5851784A (en) Human phosphodiesterase type IVC, and its production and use
KR20010012323A (ko) 사람의 Toll-유사 수용체 단백질, 관련 시약 및 방법
WO1999022000A1 (de) Inhibitor-protein des wnt-signalwegs
ES501196A0 (es) Metodo para sintetizar dentro de un hospedador bacteriano,y secretar a traves de la membrana del hospedador,una proteinao polipeptido
Burk et al. Structure of the rat plasma membrane Ca (2+)-ATPase isoform 3 gene and characterization of alternative splicing and transcription products. Skeletal muscle-specific splicing results in a plasma membrane Ca (2+)-ATPase with a novel calmodulin-binding domain.
Hagiwara et al. Genomic organization, promoter analysis, and chromosomal localization of the gene for the mouse glial high-affinity glutamate transporter Slc1a3
Kools et al. Characterization of three novel human cadherin genes (CDH7, CDH19, and CDH20) clustered on chromosome 18q22–q23 and with high homology to chicken cadherin-7
DE69837507T2 (de) Humanes Hedgehog-Protein
Farber et al. Rat CD16 is defined by a family of class III Fc gamma receptors requiring co-expression of heteroprotein subunits.
Zurovec et al. Functional conservation and structural diversification of silk sericins in two moth species
Savino et al. Genes for Xenopus laevis U3 small nuclear RNA
CN102154300B (zh) 中国南海疣镐芋螺神经毒素及其编码序列和用途
EP1015583B1 (de) Srcr domäne-enthaltendes protein
Gawin et al. A 7.5 Mb sequence-ready PAC contig and gene expression map of human chromosome 11p13–p14. 1
Mansikka et al. D‐D Recombination Diversifies the CDR 3 Region of Chicken Immunoglobulin Heavy Chains

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305163-1